ABBV, AMGN, SYK and DXCM are well-poised to benefit from the evolving new opportunities in Seniors & Aging Demographics within healthcare.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...

The green light for the pre-filled, single-use pen version of Tezspire (tezepelumab ... without any phenotypic and biomarker limitation. At the moment the biologic is delivered as a pre-filled ...

Novartis hopes to use the biomarker to develop both imaging agents ... Genmab and reformulated into its Sensoready autoinjector pen. Kesimpta's EU approval follows a green light in the US last ...

The pen-sized device produces high-resolution digital ... efficient and scalable EXO-NET exosome isolation technology for biomarker discovery and diagnostics development. The platform compares ...

The drug offers patients the first pre-filled pen presentation for monthly subcutaneous ... junction adenocarcinoma. The CLDN18.2 biomarker is expressed by about 35% of Chinese stomach cancer ...

The biomarker uses standard short-read very low-coverage whole ... Lesions with low epithelial content were sectioned onto UV-treated, PEN-membrane covered slides (Zeiss) to allow for epithelial ...

The pen-sized device produces high-resolution digital pathology ... The company said it had commercialised its fast, efficient and scalable EXO-NET exosome isolation technology for biomarker discovery ...

“Alternative splicing is a potential biomarker warning… A small molecule called ESI1 stimulated the repair of the myelin sheath, the fatty coating on nerve fibers that is damaged in multiple ...

Tissue sections (5 μm) were fixed with acetone for 10 minutes at RT, air dried, encircled with a hydrophobic pen, washed in PBS and blocked with ... Moreover, in these diseases IgA autoantibodies may ...